FDA
Zepbound (Tirzepatide) FDA-Approved for Chronic Weight Management
FDA Authorizes First Digital Therapy App for Type 2 Diabetes Management
FDA-approved AspyreRx is a digital therapy app for type 2 diabetes that uses CBT to boost wellness and glucose management via smartphone.
FDA Approves Farxiga in US for Chronic Heart Failure
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
Rybelsus, the First GLP-1 Pill, Approved for Type 2 Diabetes in Europe
Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on Saturday
Dietary Supplement Companies Are Making False Claims, FDA and FTC Warns
The FDA and the FTC sent warning letters to 10 companies falsely claiming to sell dietary supplements that could cure, treat, mitigate, or prevent diabetes. People are strongly encouraged to avoid these products until they have undergone the proper testing.
FDA Issues Safety Statement that SGLT-2 Inhibitors May Cause Diabetic Ketoacidosis
The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now. Twitter Summary: @US_FDA warns SGLT-2 inhibitors may cause DKA in some patients w/out #hyperglycemia. Get the inside scoop from Dr. Anne Peters.